Envestnet Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Envestnet Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$408K	Buy	+24,040	New	+$384K	﹤0.01%	4237
2022 Q4	–	Sell	-25,838	Closed	-$194K	–	3950
2022 Q3	$194K	Sell	25,838 -3,390	-12%	-$29.3K	﹤0.01%	3594
2022 Q2	$294K	Buy	29,228 +411	+1%	+$4.59K	﹤0.01%	3367
2022 Q1	$357K	Sell	28,817 -5,104	-15%	-$78.9K	﹤0.01%	3345
2021 Q4	$776K	Sell	33,921 -3,605	-10%	-$85.4K	﹤0.01%	2795
2021 Q3	$830K	Sell	37,526 -10,774	-22%	-$171K	﹤0.01%	2661
2021 Q2	$626K	Buy	48,300 +5,092	+12%	+$64.9K	﹤0.01%	2832
2021 Q1	$561K	Buy	+43,208	New	+$627K	﹤0.01%	2776

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management's AUPH Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 24,040 shares worth $408K. The stake represents ﹤0.01% of the portfolio and ranks #4237 among its holdings. This is a return to the name: Envestnet Asset Management previously reported a position in AUPH as recently as Q3 2022.

Envestnet Asset Management first reported a position in AUPH in Q1 2021 and has held it in 8 quarters since. The position peaked at $830K in Q3 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Envestnet Asset Management held 24,040 shares of Aurinia Pharmaceuticals worth $408K as of Q2 2026.
Aurinia Pharmaceuticals was a new Envestnet Asset Management position in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4237 holding.
Envestnet Asset Management first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
Envestnet Asset Management's Aurinia Pharmaceuticals position peaked at $830K in Q3 2021.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.